BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
6/24/2014 - NAD Recommends RB Discontinue Certain Claims for Mucinex Products, Company to Appeal
The National Advertising Division has recommended that Reckitt Benckiser LLC discontinue certain advertising claims for the company’s Mucinex and Maximum Strength Mucinex chest congestion relievers, including claims that “Only Mucinex has a bi-layer tablet. One side starts fast in 8 minutes. The other side keeps on working for 12 hours.” RB has said it will appeal NAD’s findings to the National Advertising Review Board (NARB). -
6/20/2014 - NAD Finds Gerber Can Support Certain Claims Challenged by Nurture, Inc., Recommends Company Modify Claim for ‘Good Start Gentle Formula’
The National Advertising Division has determined that Gerber Products Company can support advertising claims made on product packaging and in website advertising that various Gerber baby and toddler food products are a “good” or “excellent” source of certain nutrients. NAD recommended the company modify a claim made for Gerber Good Start Gentle Formula. -
6/19/2014 - NAD Recommends Pursuit of Research Discontinue All Challenged Claims for Supplement Marketed as ‘Cures’ for Brain Injury, ADHD, Autism
The National Advertising Division has recommended that Pursuit of Research, LLC, discontinue all challenged claims for the company’s Nutriiveda dietary supplements, which are marketed as “cures” for conditions that include attention deficit disorder, apraxia, autism, diabetes, dyspraxia, seizures, traumatic brain injury and stroke. The advertiser said it will appeal NAD’s decision to the National Advertising Review Board (NARB.) -
6/12/2014 - NAD Determines Aggregated Online Reviews Don’t Support Claims that Euro-Pro’s Shark Vacuums Are ‘America’s Most Recommended,’ Euro-Pro to Appeal
The National Advertising Division, in a case of first impression, determined that survey information culled from multiple online venues was insufficiently reliable and representative to support a broad “America’s Most Recommended” claim. -
6/12/2014 - NAD Finds Westport Can Support Claims for ZEPHREX-D Following Challenge by Acura Pharmaceuticals
The National Advertising Division has determined that Westport Pharmaceuticals, LLC, maker of ZEPHREX-D nasal decongestant tablets, can support the claims challenged before NAD by Acura Pharmaceuticals, Inc., the maker of NEXAFED, a competing product. -
6/10/2014 - NAD Recommends iSatori Discontinue Certain Claims for ‘Energize’ Supplement, Finds Company Can Support Certain Claims
The National Advertising Division has recommended that iSatori, Inc., discontinue certain claims for the company’s Energize dietary supplement, including claims of “8-Hour Efficacy Shown in Clinical Testing.” NAD determined, however, that the advertiser could support certain claims. -
6/08/2014 - Bell Commits to Discontinue Certain Claims for ‘Virux’ Product; NAD Finds Advertiser Can Support Certain Claims
Bell Lifestyle Products has discontinued certain advertising claims for the company’s “Virux Viral Infections #42,” dietary supplement, action that NAD had determined was necessary. NAD further determined that the company provided adequate substantiation for certain immune-support claims. -
6/04/2014 - NAD Finds General Mills Can Support Certain Yoplait ‘Greek’ Yogurt Taste-Test Claims, but Recommends Advertiser Modify or Discontinue Certain Comparative Claims Against Chobani
The National Advertising Division has determined that General Mills, Inc., can support certain claims made for its Yoplait “Greek” yogurt in online advertising and social media, but recommended the advertiser discontinue or modify certain claims. -
6/04/2014 - NAD Recommends Hyperion Management Discontinue All Challenged Claims ‘Garcinia Cambogia Formula,’ Better Qualify Guarantee for ‘SaferColon’
The National Advertising Division has recommended Hyperion Management, LLC, which markets the dietary supplements “Garcinia Cambogia Formula” and “SaferColon,” discontinue all challenged claims for the cambogia product and better disclose limitations the guarantee offered with “SaferColon.” -
5/21/2014 - NAD Recommends Nurture Modify, Discontinue Certain Claims for ‘Happy Family’ Baby Food; Finds Advertiser Can Support Certain ‘Organic’ Claims
The National Advertising Division has recommended that Nurture, Inc., the maker of Happy Family infant and toddler food products, modify or discontinue certain claims, including claims that state or imply that conventional or non-organic products are less nutritious, expose babies and toddlers to pesticides or contain genetically modified organisms (GMOs.) NAD did find, however, that the advertiser could continue its “organic superfoods,” “organic baby food,” and “always organic” claims.